A while ago, I posed a question about HPV.  I want to publicly thank Dr. LOVEROFWOMEN, his response was absolutely accurate.

I took my SO to an OBGYN, and a complete examination proved there was no trace of HPV.  Whatever it was 20+years ago, the immune system must have suppressed it.

Now, if we could have a good stock picker on the board!

"Now, if we could have a good stock picker on the board!" -- Curious 1


that's easy ... go with Merck (for their AIDS vaccine)

http://www.technologyreview.com/articles/cohen0302.asp


btw, i'm NOT affiliated with Merck (or MIT) ... LOL

Watch out for the AIDS vaccine.  The initial clincial trials showed only muted efficacy in the smallest racial groups in the study.  The problem with HIV is we are seeing that the mutations that occur from the medication failures are being transmitted to new infectees.  In other words instead of getting the wild type (+) strain and having the full component of meds available some new infectees are starting behind the 8-ball with a limited number of medications.  Therefore, in the vaccine is not going to be able to protect against mutated HIV viruses.  It's possible niche will be in newly infected areas where the wild type HIV virus is dominant.

I used to pick stock fairly well.  But, then I hurt my back, and I can't reach the upper shelves any more.  Now I'm in shipping.